Market Place
Sourcing Support
Lytix Biopharma to present at the `Frontiers in Cancer Immunotherapy 2023
03 May 2023 //
BUSINESSWIRE
Lytix Biopharma: Invitation to presentation of fourth quarter results
09 Feb 2023 //
PR NEWSWIRE
Lytix Biopharma appoints Stephen Worsley as Chief Business Officer
05 Sep 2022 //
PRNEWSWIRE
Lytix Biopharma: Second quarter and first half of 2022 results
25 Aug 2022 //
PRNEWSWIRE
Lytix Biopharma announces that an abstract on LTX-315 + Adoptive Cell Therapy
15 Aug 2022 //
PRNEWSWIRE
Lytix Biopharma AS announces that an abstract on LTX-315 + Adoptive Cell Therapy
26 May 2022 //
PRNEWSWIRE
Lytix Biopharma to present at the ASCO Annual Meeting
28 Apr 2022 //
PRNEWSWIRE
Lytix Bio receives milestone payment after dosing of first patient with LTX-315
05 Apr 2022 //
PRNEWSWIRE
Lytix Biopharma announces positive phase I data for LTX-315
10 May 2021 //
CISION
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.